Imagine that a pharmaceutical company has announced that the…
Imagine that a pharmaceutical company has announced that they have developed a COVID-19 vaccine after extensive human trial testing with over 200,000 adult human participants. During their press conference, they shared their results. In terms of whether the drug reduces contracting COVID-19 after exposure, the results found a small but statistically significant reduction in contracting COVID-19 with the vaccinated group versus the placebo group. In terms of whether the vaccine was safe, the results indicated that the vaccinated group had more deaths than the placebo group, but the difference was not statistically significant. Given these results, which of the following best represents how the FDA would rule in terms of this vaccine’s emergency approval?
Read Details